Literature DB >> 30439562

Calcium signalling and breast cancer.

Choon Leng So1, Jodi M Saunus2, Sarah J Roberts-Thomson3, Gregory R Monteith4.   

Abstract

The past two decades have seen the identification of important roles for calcium signalling in many of the hallmarks of cancer. One of the cancer types that has been a particular focus of such studies is breast cancer. The breast is intrinsically linked to the calcium ion due to the importance of milk calcium in neonatal growth and development. Indeed, some of the calcium channels and pumps involved in transporting calcium ions into milk also have altered expression in some breast cancers. However, altered expression is not confined to channels and pumps important in lactation, other calcium channels and pumps may also be modulated and may even be specific to breast cancer molecular subtypes. This review considers calcium signalling in the context of breast cancer and provides an overview of the roles that have been attributed to specific regulators of cellular calcium levels in processes relevant to breast cancer progression. Emerging areas in the study of calcium signalling in breast cancer are considered, such as the intersection between calcium signalling, the tumour microenvironment and breast cancer.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Calcium; Calcium signalling; Cancer; ORAI channels; TRP channels

Mesh:

Substances:

Year:  2018        PMID: 30439562     DOI: 10.1016/j.semcdb.2018.11.001

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  21 in total

1.  Flaxseed as an Anticardiotoxicity Agent in Breast Cancer Therapy.

Authors:  Ghassan Bkaily; Danielle Jacques
Journal:  J Nutr       Date:  2020-09-01       Impact factor: 4.798

2.  Triple-Negative Breast Cancer Cells Exhibit Differential Sensitivity to Cardenolides from Calotropis gigantea.

Authors:  Petra J Pederson; Shengxin Cai; Chase Carver; Douglas R Powell; April L Risinger; Tanja Grkovic; Barry R O'Keefe; Susan L Mooberry; Robert H Cichewicz
Journal:  J Nat Prod       Date:  2020-07-10       Impact factor: 4.050

3.  Calcium Metabolism and Breast Cancer: Echoes of Lactation?

Authors:  Diego Grinman; Diana Athonvarungkul; John Wysolmerski; Jaekwang Jeong
Journal:  Curr Opin Endocr Metab Res       Date:  2020-11-21

4.  Expression and associated epigenetic mechanisms of the Ca2+-signaling genes in breast cancer subtypes and epithelial-to-mesenchymal transition.

Authors:  Andrés Hernández-Oliveras; Ángel Zarain-Herzberg
Journal:  J Cell Commun Signal       Date:  2021-11-11       Impact factor: 5.908

Review 5.  Transient receptor potential cation channel subfamily V and breast cancer.

Authors:  Choon Leng So; Michael J G Milevskiy; Gregory R Monteith
Journal:  Lab Invest       Date:  2019-12-10       Impact factor: 5.662

Review 6.  Relevance of Membrane Contact Sites in Cancer Progression.

Authors:  Aurora Gil-Hernández; Miguel Arroyo-Campuzano; Arturo Simoni-Nieves; Cecilia Zazueta; Luis Enrique Gomez-Quiroz; Alejandro Silva-Palacios
Journal:  Front Cell Dev Biol       Date:  2021-01-12

7.  TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.

Authors:  María Paz Saldías; Diego Maureira; Octavio Orellana-Serradell; Ian Silva; Boris Lavanderos; Pablo Cruz; Camila Torres; Mónica Cáceres; Oscar Cerda
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

Review 8.  Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers.

Authors:  Zhengfeng Yang; Zhiying Yue; Xinrun Ma; Zhenyao Xu
Journal:  Front Oncol       Date:  2020-03-10       Impact factor: 6.244

9.  Sevoflurane modulates breast cancer cell survival via modulation of intracellular calcium homeostasis.

Authors:  Xiaoqian Deng; Megha Vipani; Ge Liang; Divakara Gouda; Beibei Wang; Huafeng Wei
Journal:  BMC Anesthesiol       Date:  2020-09-29       Impact factor: 2.217

Review 10.  Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.